Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi-Ping Day

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Nature Medicine|April 15, 2020
Multimodel preclinical platform predicts clinical response of melanoma to immunotherapyEva Pérez-Guijarro, Howard H Yang, Romina E Araya, et al.
Nature Medicine|January 30, 2021
Author Correction: Multimodel preclinical platform predicts clinical response of melanoma to immunotherapyEva Pérez-Guijarro, Howard H Yang, Romina E Araya, et al.
Nature Communications|May 12, 2023
Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy responseMeghana Pagadala, Timothy J Sears, Victoria H Wu, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Severus: accurate detection and characterization of somatic structural variation in tumor genomes using long readsAyse Keskus, Asher Bryant, Tanveer Ahmad, et al.
Nature Biotechnology|April 4, 2025
Severus detects somatic structural variation and complex rearrangements in cancer genomes using long-read sequencingAyse G Keskus, Asher Bryant, Tanveer Ahmad, et al.
Nature Communications|April 4, 2019
Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5<sup>-/-</sup> miceYan Li, Roberto Tinoco, Lisa Elmén, et al.
Biorxiv : the Preprint Server for Biology|August 1, 2025
Pan-cancer prediction of tumor immune activation and response to immune checkpoint blockade from tumor transcriptomics and histopathologySumit Mukherjee, Sumeet Patiyal, Lipika R Pal, et al.
Science Translational Medicine|February 4, 2026
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cellsIvan J Cohen, Audrey C Bochi-Layec, Jean Lemoine, et al.
Nature|February 28, 2020
Epigenetic therapy inhibits metastases by disrupting premetastatic nichesZhihao Lu, Jianling Zou, Shuang Li, et al.
Science (New York, N.Y.)|December 23, 2021
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy responseChristine N Spencer, Jennifer L McQuade, Vancheswaran Gopalakrishnan, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Nature Medicine|April 15, 2020
Multimodel preclinical platform predicts clinical response of melanoma to immunotherapyEva Pérez-Guijarro, Howard H Yang, Romina E Araya, et al.
Nature Medicine|January 30, 2021
Author Correction: Multimodel preclinical platform predicts clinical response of melanoma to immunotherapyEva Pérez-Guijarro, Howard H Yang, Romina E Araya, et al.
Nature Communications|May 12, 2023
Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy responseMeghana Pagadala, Timothy J Sears, Victoria H Wu, et al.
Medrxiv : the Preprint Server for Health Sciences|April 8, 2024
Severus: accurate detection and characterization of somatic structural variation in tumor genomes using long readsAyse Keskus, Asher Bryant, Tanveer Ahmad, et al.
Nature Biotechnology|April 4, 2025
Severus detects somatic structural variation and complex rearrangements in cancer genomes using long-read sequencingAyse G Keskus, Asher Bryant, Tanveer Ahmad, et al.
Nature Communications|April 4, 2019
Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5<sup>-/-</sup> miceYan Li, Roberto Tinoco, Lisa Elmén, et al.
Biorxiv : the Preprint Server for Biology|August 1, 2025
Pan-cancer prediction of tumor immune activation and response to immune checkpoint blockade from tumor transcriptomics and histopathologySumit Mukherjee, Sumeet Patiyal, Lipika R Pal, et al.
Science Translational Medicine|February 4, 2026
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cellsIvan J Cohen, Audrey C Bochi-Layec, Jean Lemoine, et al.
Nature|February 28, 2020
Epigenetic therapy inhibits metastases by disrupting premetastatic nichesZhihao Lu, Jianling Zou, Shuang Li, et al.
Science (New York, N.Y.)|December 23, 2021
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy responseChristine N Spencer, Jennifer L McQuade, Vancheswaran Gopalakrishnan, et al.
Pageof 8